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ABSTRACT 
Study title: 
FETOMATERNAL OUTCOME IN HELLP 
SYNDROME COMPLICATING PREGNANCY 
Background:   
HELLP syndrome is a severe complication of preeclampsia and Eclampsia with 
high risk for mother and fetus. It comprises of  hemolysis, elevated liver enzymes and 
low platelet count. HELLP is an acroynm coined by Weinstein in 1982. In HELLP 
syndrome there is high maternal and perinatal morbidity due to under diagnosis and 
delayed treatment of preeclampsia.  The developed nations have achieved great success 
in combating HELLP syndrome and the research activities today focuses on the early 
predictors of preeclampsia but developing nations have long way to go. 
 
Objectives: 
The objective of this study is to detect and evaluate the fetomaternal outcome in 
HELLP syndrome complicating pregnancy. To study  the incidence of  HELLP 
syndrome,toanalyse the clinical profile of  HELLP syndrome cases, to study the maternal 
and perinatal outcome  including morbidity and mortality 
 
Methods and materials: 
Case sheets from the Medical records department in institute of obstetrics and 
gynaecology ,Egmore, Chennai from period of JUNE 2013 to May 2015  
         A retrospective analysis was done in 86 patients who were diagnosed as HELLP 
syndrome complicating pregnancy and admitted in Department of Obstetrics and 
gynaecology, Institute of obstetrics and Gynaecology, Madras Medical College.          
  A complete review of all clinical case sheets were undertaken regarding the 
clinical history, examination and diagnostic investigations. Various factors whether 
independent or dependent were identified which were related to the mortality and 
morbidity of the fetus and the mother 
 
 
Results: 
During the study period July 2013 to June 2015, there was about 75 cases of 
maternal death. Of which 28 cases were due to HELLP Syndrome. This contributes to 
1/3
rd
 of the total maternal deaths. Among the 86 patients of HELLP syndrome 54 were 
referred from other hospitals in which IOG was found to be 3
rd
 or 4
th
 referral centre. 
Our study calculated the prevalence of HELLP syndrome as (2.6%)   while the 
prevalence of partial HELLP as (2.08%). Significant association was found between 
serum bilirubin values and maternal death. Values >2.2 is more associated with the 
higher incidence of maternal death. Sensitivity of association between SGOT and the 
incidence of maternal death was found to be 82.1%. Serum bilirubin level of above 
2.3mg/dl is associated with a higher incidence of IUD. It was found that LDH value of 
more than 2320 was significantly associated with higher incidence of IUD. Most of the 
patients in our study were Multigravida (53%) and less than 25 years old. Values of LDH 
above 2557 was found to be significantly associated with the higher incidence of LBW. 
The cesarean section rate in HELLP and partial HELLP syndrome were very high in our 
study as the pregnancy was terminated as soon as the disease was diagnosed to avoid 
worsening of maternal and perinatal outcomes. Placental abruption corroborated with the 
bad perinatal prognosis in both HELLP and partial HELLP syndrome. In our study DIVC 
was found to be most common complication. The rate of eclampsia in HELLP syndrome 
group and partial HELLP syndrome group were significantly higher as shown in our 
study 
 
Conclusion: 
Most of the deaths are due to underdiagnosis and delayed diagnosis and patients 
being referred during late stages when the patients develop complete HELLP syndrome 
where there is more morbidity and mortality. Proper education of the health personnel 
about the signs and symptoms, proper routine antenatal check up and warning signs and 
symptoms and laboratory investigations can be much helpful to make an early diagnosis 
and management and thus preventing and decreasing the incidence of maternal deaths. 
 
KEY WORDS: 
Pre eclampsia, HELLP syndrome, partial HELLP syndrome. 
 
